Growth Metrics

Cytosorbents (CTSO) Current Leases (2018 - 2026)

Cytosorbents posted quarterly Current Leases of $565000.0 for Q1 2026, up 19.23% year-on-year from $473889.0 in Q1 2025, and up 4.44% on a QoQ basis from $541000.0 in Q4 2025.

Cytosorbents (CTSO) has 9 years of Current Leases data on file, last reported at $565000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 19.23% year-over-year to $565000.0; the trailing twelve-month figure through Mar 2026 stood at $565000.0 (up 19.23% YoY), and the FY2025 full-year result was $541000.0, up 19.43% from the prior year.
  • Current Leases for Q1 2026 stood at $565000.0, up from $541000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $565000.0 in Q1 2026 and bottomed at $108939.0 in Q4 2022.
  • The 5-year median for Current Leases is $416861.0 (2022), against an average of $375806.6.
  • The widest annual swing landed in 2022, when Current Leases tumbled 80.91%; it then surged 268.59% in 2024.
  • A 5-year view of Current Leases shows it stood at $108939.0 in 2022, then soared by 242.98% to $373636.0 in 2023, then advanced by 21.24% to $453000.0 in 2024, then climbed by 19.43% to $541000.0 in 2025, then climbed by 4.44% to $565000.0 in 2026.
  • The last three Current Leases figures came in at $565000.0 (Q1 2026), $541000.0 (Q4 2025), and $518000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 565,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 565,000.00
Dec 31, 2025 541,000.00
Sep 30, 2025 518,000.00
Jun 30, 2025 495,000.00
Mar 31, 2025 473,889.00
Dec 31, 2024 453,000.00
Sep 30, 2024 431,997.00
Jun 30, 2024 412,067.00
Mar 31, 2024 392,617.00
Dec 31, 2023 373,636.00
Sep 30, 2023 117,204.00
Jun 30, 2023 114,382.00
Mar 31, 2023 111,627.00
Dec 31, 2022 108,939.00
Sep 30, 2022 376,529.00
Jun 30, 2022 416,861.00
Mar 31, 2022 486,964.00
Dec 31, 2021 570,566.00
Sep 30, 2021 265,675.00
Jun 30, 2021 251,524.00
Mar 31, 2021 462,896.00
Dec 31, 2020 447,485.00
Sep 30, 2020 432,423.00
Jun 30, 2020 417,699.00
Mar 31, 2020 442,865.00
Dec 31, 2019 428,083.00
Sep 30, 2019 413,634.00
Jun 30, 2019 399,512.00
Mar 31, 2019 388,915.00
Dec 31, 2018 378,675.00